Ingevity Corporation (NYSE:NGVT) Q1 2024 Earnings Call Transcript May 4, 2024 Ingevity Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning or good afternoon. Welcome to the Ingevity First Quarter 2024 Earnings Webcast. My name is Adam and I’ll […]
HIGHLIGHTS:
Net sales of $340.1 million, down 13% primarily as a result of the repositioning of Performance Chemicals
Net loss of $56.0 million and diluted loss per share of $1.54; adjusted.
Fourth Quarter :
Net sales of $371.7 million decreased 3.1%
Net loss of $116.8 million and diluted loss per share of $3.23, including restructuring charges of $107.5 million; adjusted earnings.